Correlation Between Pmv Pharmaceuticals and Structure Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Structure Therapeutics American, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Structure Therapeutics.
Diversification Opportunities for Pmv Pharmaceuticals and Structure Therapeutics
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pmv and Structure is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Structure Therapeutics go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Structure Therapeutics
Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 0.46 times more return on investment than Structure Therapeutics. However, Pmv Pharmaceuticals is 2.16 times less risky than Structure Therapeutics. It trades about -0.14 of its potential returns per unit of risk. Structure Therapeutics American is currently generating about -0.1 per unit of risk. If you would invest 169.00 in Pmv Pharmaceuticals on December 1, 2024 and sell it today you would lose (32.00) from holding Pmv Pharmaceuticals or give up 18.93% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Pmv Pharmaceuticals vs. Structure Therapeutics America
Performance |
Timeline |
Pmv Pharmaceuticals |
Structure Therapeutics |
Pmv Pharmaceuticals and Structure Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pmv Pharmaceuticals and Structure Therapeutics
The main advantage of trading using opposite Pmv Pharmaceuticals and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen | Pmv Pharmaceuticals vs. Anebulo Pharmaceuticals |
Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |